Regarding the potential pathological impact of synovial resistin levels in RA, it has been shown that increased levels correlate with RA disease activity, joint damage [71], and inflammation intensity defined by the intra-articular leukocytes count and IL-6 levels [128]. This evidence concerns the gene RETN and rheumatoid arthritis.